Géraldine Teppaz

478 total citations
12 papers, 237 citations indexed

About

Géraldine Teppaz is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Géraldine Teppaz has authored 12 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Géraldine Teppaz's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Géraldine Teppaz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Géraldine Teppaz collaborates with scholars based in France, United States and Belgium. Géraldine Teppaz's co-authors include Yannick Jacques, Anne Bessard, Agnès Quéméner, Laure Garrigue‐Antar, Véronique Solé-Jamault, Mike Maillasson, Bernard Mouillac, David Béchard, Stéphane Birklé and Denis Cochonneau and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Géraldine Teppaz

12 papers receiving 232 citations

Peers

Countries citing papers authored by Géraldine Teppaz

Since Specialization

Citations

This map shows the geographic impact of Géraldine Teppaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Teppaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Teppaz more than expected).

Fields of papers citing papers by Géraldine Teppaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Teppaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Teppaz. The network helps show where Géraldine Teppaz may publish in the future.

Co-authorship network of co-authors of Géraldine Teppaz

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Teppaz. A scholar is included among the top collaborators of Géraldine Teppaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Teppaz. Géraldine Teppaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models 2023 ·SHILAP Revista de lepidopterología ·Irène Baccelli, Caroline Mary, (unknown), (unknown), (unknown), Géraldine Teppaz, Emmanuelle Wilhelm, Isabelle Girault, Vanessa Gauttier, Virginie Thépenier, (unknown), Kévin Biteau, (unknown), (unknown), (unknown), (unknown), Elise Chiffoleau, Nicolas Poirier	1
2	1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy 2023 ·SHILAP Revista de lepidopterología ·Aurore Morello, Justine Durand, (unknown), Isabelle Girault, Géraldine Teppaz, Virginie Thépenier, (unknown), (unknown), Emmanuelle Wilhelm, (unknown), Caroline Mary, Nicolas Poirier	2
3	First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα 2023 ·The Journal of Immunology ·Nicolas Poirier, Irène Baccelli, Lyssia Belarif, Riad Abès, Géraldine Teppaz, Caroline Mary, Sonia Poli, (unknown), Isabelle Girault, Sabrina Pengam, (unknown), (unknown), (unknown), Cécile Braudeau, Régis Josien, (unknown), (unknown), (unknown)	5
4	1366 Anti-PD-1/IL-7v bispecific antibody promotes TCF1+ stem like T cells expansion and long-lasting in vivo efficacy 2022 ·Regular and Young Investigator Award Abstracts ·Aurore Morello, (unknown), Justine Durand, Isabelle Girault, Géraldine Teppaz, Virginie Thépenier, Vanessa Gauttier, Caroline Mary, Nicolas Poirier	1
5	Abstract 1766: Triggering the resolution of inflammation with agonistic anti-ChemR23 antibody dampens inflammation-driven carcinogenesis 2021 ·Cancer Research ·Vanessa Gauttier, (unknown), (unknown), Kévin Biteau, Isabelle Girault, Lyssia Belarif, Géraldine Teppaz, Caroline Mary, Virginie Thépenier, Christophe Blanquart, Sophie Barillé‐Nion, Nicolas Poirier	1
6	Abstract 910: A novel bifunctional anti-PD-1 IL-7 fusion protein to reinvigorate exhausted T cell and disarms Treg suppressive activity 2020 ·Cancer Research ·Aurore Morello, Justine Durand, Virginie Thépenier, Géraldine Teppaz, (unknown), Sabrina Pengam, Caroline Mary, Nicolas Poirier	2
7	Abstract 3259: CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy controlling damaged and tumor cells phagocytosis 2020 ·Cancer Research ·Vanessa Gauttier, (unknown), (unknown), (unknown), Caroline Mary, Géraldine Teppaz, (unknown), Virginie Thépenier, Emmanuelle Wilhelm, Nicolas Poirier, Elise Chiffoleau	1
8	SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells 2019 ·American Journal of Transplantation ·Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Bernard Martinet, (unknown), Caroline Mary, Virginie Thépenier, Géraldine Teppaz, Karine Renaudin, Gilles Blancho, Bernard Vanhove, Nicolas Poirier	34
9	IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists 2016 ·The Journal of Immunology ·Mélanie Desbois, (unknown), Clélia Coutzac, Elie Marcheteau, (unknown), Magali Terme, Alain Gey, (unknown), Géraldine Teppaz, Lisa Boselli, Yannick Jacques, David Béchard, Éric Tartour, Lydie Cassard, Nathalie Chaput	51
10	Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse 2014 ·mAbs ·(unknown), Géraldine Teppaz, Laurie Lajoie, Véronique Solé-Jamault, Anne Bessard, Mike Maillasson, Séverine Loisel, David Béchard, Béatrice Clemenceau, Gilles Thibault, Laure Garrigue‐Antar, Yannick Jacques, Agnès Quéméner	32
11	Tumor targeting of the IL‐15 superagonist RLI by an anti‐GD2 antibody strongly enhances its antitumor potency 2013 ·International Journal of Cancer ·(unknown), Anne Bessard, Denis Cochonneau, Géraldine Teppaz, Véronique Solé-Jamault, Mike Maillasson, Stéphane Birklé, Laure Garrigue‐Antar, Agnès Quéméner, Yannick Jacques	60
12	Toward Efficient Drug Screening by Homogeneous Assays Based on the Development of New Fluorescent Vasopressin and Oxytocin Receptor Ligands 2007 ·Journal of Medicinal Chemistry ·Laura Albizu, Géraldine Teppaz, René Seyer, Hervé Bazin, Hervé Ansanay, Maurice Manning, Bernard Mouillac, Thierry Durroux	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact